Sadeer J. Alzubaidi, M.D.

Closed for Enrollment

• Assess the BioTraceIO System Ability to Identify Tissue Damage of Microwave Thermal Liver Ablation Using Ultrasound Data Scottsdale/Phoenix, Ariz.

  The purpose of this study is to evaluate the accuracy of the BioTrace IO during RFA/MWA Transcutaneous procedures.

• Pivotal Clinical Study to Establish the Safety and Effectiveness of the Use of BioTraceIO Lite for Assessment of Tissue Damage following Liver Tissue Ablation Procedures (CL000012) Rochester, Minn., Scottsdale/Phoenix, Ariz.

  The purpose of the study is to look at the safety and effectiveness of using BioTraceIO Lite software during an ultrasound for patients who are having a liver ablation procedure.